Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

New approaches to personalised medicine

Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany
New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )
18 May 2012

Goals of the German Consortium for Translational Cancer Research

Dr Hubert Serve – University of Frankfurt, Germany
Goals of the German Consortium for Translational Cancer Research ( Dr Hubert Serve – University of Frankfurt, Germany )
18 May 2012

Recent developments in neoadjuvant therapy

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
17 May 2012

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium
Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )
17 May 2012

Endocrine therapy and endocrine resistant breast cancer

Prof Mitch Dowsett – The Institute for Cancer Research, London, UK
Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK )
17 May 2012

Overcoming drug resistance and targeting critical pathways

Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA
Overcoming drug resistance and targeting critical pathways ( Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA )
17 May 2012

Heterogeneity of tumours and the challenges of biomarker development

Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy
Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )
17 May 2012

Targeting the PI3K/mTOR pathway

Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA
Targeting the PI3K/mTOR pathway ( Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA )
17 May 2012

Use of metformin against breast cancer

Prof Alastair Thompson – University of Dundee, UK
Use of metformin against breast cancer ( Prof Alastair Thompson – University of Dundee, UK )
17 May 2012

Cancer genes differ in different parts of a tumour

Prof Charles Swanton - CRUK London Research Institute and UCL, UK
Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )
17 May 2012

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012

Endocrine therapy resistance and next generation sequencing

Prof Matthew Ellis - Washington University, USA
Endocrine therapy resistance and next generation sequencing ( Prof Matthew Ellis - Washington University, USA )
17 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation